Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with mild Alzheimer's disease or mild cognitive impairment (MCI, which means early-stage memory and thinking difficulties that are noticeable but not severe)
Who may not be able to join:
- People who have a serious mental health condition (such as psychosis), a genetic disorder, a metabolic condition, another neurological (brain or nervous system) disorder, or a significant physical health condition that is not well managed
- People whose memory, thinking, or mood is affected by a medical condition or by medications they are taking
- People who currently use or have a history of misusing alcohol or illegal drugs
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +390652253440
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Identification of Disease-Associated Phenotypes in MCI and AD; Identification of Disease-Associated Early Interventions in MCI and AD; Predictive Power of EEG-Based Brain Network Analyses for MCI to AD Conversion; Evaluation of Targeting Efficiency of Activated vs Native Leukosomes in Brain Inflammation; Evaluation Trafficking Kinetics of Activated vs Native Leukosomes in Brain Inflammation; Assessment of Activated Leukosomes in Inducing Anti-Inflammatory Polarization of Macrophages; Assessment of Activated Leukosomes in Glial Cells
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.